Jacobs Levy Equity Management, Inc Opti Nose, Inc. Transaction History

Jacobs Levy Equity Management, Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$1.55 - $3.1 $687,372 - $1.37 Million	-443,466 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$2.35 - $3.16 $1,318 - $1,772	-561 Reduced 0.13%	443,466 $1.33 Million
Q2 2021 Aug 16, 2021	SELL	$2.91 - $3.83 $60,175 - $79,200	-20,679 Reduced 4.45%	444,027 $1.38 Million
Q1 2021 May 17, 2021	BUY	$3.47 - $4.75 $1.55 Million - $2.13 Million	448,094 Added 2697.41%	464,706 $1.72 Million
Q4 2020 Feb 16, 2021	BUY	$3.2 - $4.98 $53,158 - $82,727	16,612 New	16,612 $69,000

88.3M

Ticker OPTN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 83,277,504
Market Cap $36.6M
Description
OptiNose, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of products for patients treated by ear, nose, throat, and allergy specialists in the United States. The company offers XHANCE, a therapeutic product utilizing its proprietary exhalation delivery system (EDS) that delivers a topically-acting cort...

Get notified when there are updates to the investment portfolio of Jacobs Levy Equity Management, Inc, based on Form 13F filings with the SEC.

Stay updated on Jacobs Levy Equity Management, Inc with notifications on news.